Selective activator of cGMP-dependent protein kinase (PKG) Iα, Iβ, and type II as well as of cGMP-gated ion channels. Higher activation potential as compared to cGMP; excellent cell membrane permeability and phosphodiesterase stability. Preferred alternative to unsuitable analogs such as dibutyryl-cGMP.
Product Details
| Alternative Name: | 8-pCPT-cGMP . Na |
| |
| Formula: | C16H14ClN5O7PS . Na |
| |
| MW: | 486.8 . 23.0 |
| |
| CAS: | 51239-26-0 |
| |
| Purity: | ≥99% (HPLC) |
| |
| Identity: | Determined by ESI-MS and UV/VIS. |
| |
| Appearance: | White to off-white powder. |
| |
| Solubility: | Soluble in water. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP: E. Butt, et al.; Biochem. Pharmacol.
43, 2591 (1992),
Abstract;
Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets: J. Geiger, et al.; PNAS
89, 1031 (1992),
Abstract;
